Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules

Anticancer Res. 2013 Oct;33(10):4373-80.

Abstract

Cannabinoids are the bioactive components of the Cannabis plant that display a diverse range of therapeutic qualities. We explored the activity of six cannabinoids, used both alone and in combination in leukaemic cells. Cannabinoids were cytostatic and caused a simultaneous arrest at all phases of the cell cycle. Re-culturing pre-treated cells in drug-free medium resulted in dramatic reductions in cell viability. Furthermore, combining cannabinoids was not antagonistic. We suggest that the activities of some cannabinoids are influenced by treatment schedules; therefore, it is important to carefully select the most appropriate strategy in order to maximise their efficacy.

Keywords: Cannabinoids; drug combination; drug schedule; leukaemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cannabidiol / pharmacology*
  • Cannabinoids / pharmacology
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Drug Administration Schedule
  • Drug Synergism
  • HL-60 Cells
  • Humans
  • Inhibitory Concentration 50
  • Signal Transduction

Substances

  • Antineoplastic Agents
  • Cannabinoids
  • Cannabidiol
  • cannabigerol